James E. Calvin is the Richard Ivey Chair of Internal Medicine of Western University in London, Ontario, and the chief of medicine of London’s Affiliated Hospitals. After a post-doctoral fellowship at the University of California at San Francisco, he was appointed assistant professor at the University of Ottawa and later became the director of the Coronary Care Unit at the Ottawa Heart Institute. Calvin also was the first director of Technical Services at the Heart Institute in the 1980s and was asked to become vice chairman of the newly formed Working Group on Critical Care Services for the Ministry of Health of Ontario in 1989.

Calvin returned to the U.S. in 1991 to become the founding director of the CCU at Rush University. He was appointed Herrick Professor of Cardiology at Rush in 2002 and served as its director of the Division of Cardiology for 10 years. Calvin served as president of the Canadian Association of Professors of Medicine and served as the chief medical officer and executive vice president at London Health Science Center in 2018-2019. He founded the Center of Quality, Innovation and Safety at Western in 2020 and serves as its first medical director, and he was LHSC’s interim medical executive in 2022-2023. He completed his MBA at the University of Tennessee in 2012 before taking the position at Western.

Calvin acted as a steering committee member of the national CRUSADE registry and was co-principal investigator of the NIH-sponsored Heart Failure Adherence and Retention Trial (HART) and the Congestive Heart Failure Adherence Redesign Trial (CHART) study and its pilot and served as chairperson of Adult Cardiology at Stroger Hospital of Cook County. He received the Quentin Young Leadership Award from Cook County Hospital Department of Medicine in 2000. During his time in Ottawa, the U.S. Society of Critical Care Medicine presented him the Young Investigator Award in 1986 and the Internal Medicine Award in 1988 for his studies of ventricular interactions in critical Illness.

He published the first validated risk patient stratification model in acute coronary syndromes and later updated this model with the addition of serum markers. His model also predicted resource utilization and clinical outcome. More importantly, Calvin demonstrated the value of providing decision support to treating physicians in the form of reminders improving both quality and short-term outcomes.

He was appointed Herrick Professor of Cardiology at Rush in 2002 and served as its Director of the Division of Cardiology for 10 years. He completed his MBA at the University of Tennessee in 2012 before taking the position at Western. He served as President of the Canadian Association of Professors of Medicine and served as the Chief Medical Officer and Executive Vice President at London Health Science Center in 2018-2019. He founded the Center of Quality, Innovation and Safety at Western in 2020 and serves as its first Medical Director. He was the Interim Medical Executive at LHSC 2022-2023. He lectures about the Canadian Health Care System at UT’s Haslam College of Business. He has published 336 papers (125), abstracts (139), review articles (25), guideline tools (six), and he has edited 13 books and 31 book chapters. He has been principal or co-principal investigator on 20 peer review grants.